Navigation
Table of Contents
Section One
Executive Summary
DM-XTech UK Ltd is the exclusive licensee of DM-XTechnologies Inc. for the production, marketing and distribution of a portfolio of advanced low-carbon fuels across the United Kingdom and European Union. The Company holds exclusive rights to four proprietary fuel products — tLCAF, zLCAF, Universal Marine Fuel and Euro7-Ready Diesel — each representing a step-change improvement over incumbent fuels in toxicology, emissions and regulatory compliance.
This Memorandum seeks USD 50 million (approximately GBP 40 million) in Series A financing to establish and operate a TERC Commercial Pilot Plant at the University of Sheffield Translational Energy Research Centre (TERC), commence front-end engineering for a dedicated commercial refinery, and fund a 36-month operating runway. The Pilot Plant will serve three simultaneous commercial functions: fulfil the initial fuel supply requirement for a proposed UK Ministry of Defence Operational Pilot Programme; supply first-adopter airlines seeking to achieve compliance with EU Regulation 2024/2493 on Non-CO₂ emissions; and generate the commercial operating data required to anchor a dedicated refinery financing.
DM-XTech occupies a uniquely privileged commercial position: it is the only company in the world with a validated, drop-in, ASTM D1655-certified aviation fuel that simultaneously eliminates naphthalene toxicity (addressing the MOD aerotoxic crisis), reduces soot particulate mass by 80% and contrail formation by 40–50% (addressing EU 2024/2493 Non-CO₂ regulations), and maintains legacy seal integrity through precision aromatic engineering.
Investment Highlights at a Glance
Three-Stage Value Creation Roadmap
Section Two
Company Overview & Licence Structure
2.1 Corporate Structure
DM-XTech UK Ltd is a UK-registered advanced fuel technology company and the exclusive territorial licensee of DM-XTechnologies Inc. for the production, marketing and distribution of a portfolio of proprietary next-generation fuels across the United Kingdom and European Union.
DM-XTechnologies Inc. is the IP originator and parent technology company, holding all core patents, formulation specifications, process know-how and regulatory certifications for the fuel portfolio. DM-XTechnologies Inc. has granted DM-XTech UK Ltd an exclusive, royalty-bearing licence for the UK/EU territory, with rights to sub-licence production to qualifying refinery partners under DM-XTech's oversight and quality assurance framework.
The Licence Advantage
The exclusive territorial licence structure is a significant commercial barrier to competition. No competitor can produce, market or distribute the licensed fuel products in the UK or EU without DM-XTech's consent. This creates a structural monopoly position over the licensed territory for the duration of the licence term, giving investors the certainty of a defensible market position that is independent of patent registration timelines.
The licence covers: tLCAF (Transitional Low Carbon Aviation Fuel) · zLCAF (Zero-Aromatics Low Carbon Aviation Fuel) · Universal Marine Fuel · Euro7-Ready Diesel Fuel · and any subsequent fuel products developed by DM-XTechnologies Inc.
2.2 Academic Partnership — University of Sheffield TERC
The Translational Energy Research Centre (TERC) at the University of Sheffield is DM-XTech's primary scientific validation, quality assurance and commercial production partner. TERC conducted the independent testing programme on the Honeywell 131-9A Auxiliary Power Unit that generated all performance data cited in this Memorandum.
The decision to site the Commercial Pilot Plant within the TERC compound confers multiple advantages: continued access to TERC's analytical infrastructure for ongoing quality assurance; independent academic oversight that reinforces the scientific credibility of production batches; institutional support for regulatory engagement with the MOD, CAA and EASA; and the reputational weight of a Russell Group university association that accelerates commercial negotiations with airlines and the MOD.
2.3 Intellectual Property
Core IP licensed from DM-XTechnologies Inc. includes the tLCAF hydrotreatment process specification achieving zero naphthalene with precision 8.5% aromatic retention; the zLCAF fully zero-aromatic formulation currently in advanced TERC validation; the Universal Marine Fuel combustion profile; and the Euro7-Ready Diesel formulation meeting forthcoming EU7 emission standards ahead of legislative enforcement.
DM-XTech UK Ltd is filing additional patent protection in the UK and EU covering the 8.5% cycloparaffin aromatic blend methodology, the seal integrity validation protocol, and the tLCAF production quality control framework.
| Asset | Status |
|---|---|
| tLCAF Formulation | Licensed (excl. UK/EU) + UK patent filing |
| Hydrotreatment Process | Licensed (excl. UK/EU) + EU patent filing |
| 8.5% Aromatic Blend Method | UK/EU patent application in preparation |
| zLCAF Formulation | Licensed (excl. UK/EU) |
| Universal Marine Fuel | Licensed (excl. UK/EU) |
| Euro7 Diesel | Licensed (excl. UK/EU) |
| TERC QA Protocol | DM-XTech UK proprietary |
2.4 Intellectual Property & Licence Status
DM-XTech UK Ltd operates under a general exclusivity agreement with DM-XTechnologies Inc., granting DM-XTech exclusive rights to produce, market and distribute the entire licensed fuel portfolio across the UK and EU. There are currently no financial obligations under the existing licence agreement — the royalty structure (3–5% of net revenue) activates only upon first commercial sales.
| Item | Status |
|---|---|
| Licence Type | General exclusivity — UK & EU territory |
| Licensor | DM-XTechnologies Inc. |
| Patent Applications | 3 pending (UK & EU filings) |
| Trade Secrets | Formulation specs, process parameters (protected under NDA) |
| Contractual Know-How | Hydrotreatment process; aromatic blend method; QA protocols |
| Current Licence Obligations | Nil (royalties activate on first revenue) |
2.5 Current Burn Rate & Pre-Series A Runway
| Metric | Detail |
|---|---|
| Current Monthly Burn Rate | USD 50,000 / month |
| Annual Burn Rate | USD 600,000 / year |
| Current Obligations Under Licence | Nil |
| Existing Debt / Borrowings | None |
| Pre-Series A Funding | Founder capital & early-stage angel investment |
DM-XTech's pre-Series A operating cost structure is deliberately lean, with monthly expenditure of USD 50,000 covering CEO compensation, legal counsel retainers, TERC engagement costs and essential regulatory filings. There are no outstanding obligations under the licence agreement with DM-XTechnologies Inc. — the royalty mechanism activates only upon first commercial revenue, meaning the Company has zero legacy financial commitments entering the Series A.
2.6 Management & Leadership
DM-XTech UK Ltd is led by a management team combining deep domain expertise in petroleum chemistry, fuel technology commercialisation, regulatory strategy and capital markets. The founding team developed the tLCAF formulation concept, secured the exclusive territorial licence from DM-XTechnologies Inc., and led the engagement with the University of Sheffield TERC that produced the validation dataset underpinning this Memorandum.
| Role | Responsibility | Status |
|---|---|---|
| Chief Executive Officer | Strategic direction; investor relations; MOD & airline engagement; IP licence management | In post |
| Chief Technical Officer | TERC Pilot Plant design & commissioning; production QA; formulation oversight | Appointment post-Series A close |
| Chief Financial Officer | Financial modelling; Series B preparation; deSPAC transaction management | Appointment post-Series A close |
| Head of Commercial | Airline CPOA negotiation; MOD procurement interface; marine & diesel channels | Appointment post-Series A close |
| TERC Liaison & QA Director | University of Sheffield interface; batch certification; regulatory documentation | Appointment aligned to Pilot Plant construction |
| Legal Counsel (External) | MOD submissions; IP filings; CPOA contract execution; regulatory compliance | Retained |
| deSPAC Advisory (External) | SPAC identification; merger structuring; SEC/NASDAQ requirements | To be appointed H2 2026 |
Full management CVs, advisory board composition, and organisational charts are available in the Due Diligence Data Room upon execution of a Non-Disclosure Agreement. The Series A use of proceeds allocates GBP 4 million for C-suite management team costs over 36 months and GBP 2.8 million for general and administrative expenses, enabling the Company to recruit and retain the full executive leadership team from day one.
Section Three
The Product Suite
tLCAF — Transitional Low Carbon Aviation Fuel
Precision-engineered hydrotreated jet fuel surrogate eliminating naphthalene entirely while maintaining 8.5% cycloparaffin aromatic content for legacy NBR seal compatibility. Drop-in replacement for standard Jet A-1 across all legacy rotorcraft and fixed-wing platforms. Addresses both the MOD aerotoxic crisis and EU 2024/2493 Non-CO₂ compliance obligations of airlines. TERC-validated on Honeywell 131-9A APU.
zLCAF — Zero-Aromatics Low Carbon Aviation Fuel
Second-generation, fully zero-aromatic aviation fuel designed for modern aircraft fitted with seals that do not require controlled swelling (PTFE, FFKM and fluoropolymer seal systems standard on A320neo, A350, B737 MAX and B787 families). Eliminates the aromatic fraction entirely, achieving theoretical maximum combustion cleanliness, minimum particulate formation and maximum contrail suppression. Currently in advanced TERC validation.
Universal Marine Fuel
A single, universal low-emission marine fuel designed to replace both MGO (Marine Gas Oil) and VLSFO (Very Low Sulphur Fuel Oil) across all vessel types, from bulk carriers to naval fast patrol craft. Formulated to comply with IMO 2020 sulphur cap requirements while simultaneously delivering significant reductions in particulate matter and NOx — critical for port emission control areas (ECAs). Addresses growing pressure from the EU ETS maritime extension (2024) and IMO MEPC marine GHG strategy (2023).
Euro7-Ready Diesel Fuel
A refined diesel formulation pre-compliant with forthcoming EU7 vehicle emission standards — the most stringent diesel regulation in the EU's history, scheduled for implementation across light-duty vehicles from 2025 and heavy-duty vehicles from 2028. Euro7 limits are projected to require fuel-side intervention for significant portions of the legacy fleet; DM-XTech's formulation provides a drop-in solution enabling Euro7 compliance without vehicle modification or aftertreatment system upgrades.
3.1 tLCAF Technical Performance — TERC Validated Data
| Performance Parameter | Jet A-1 Baseline | tLCAF Result | Improvement | Health / Environmental Significance |
|---|---|---|---|---|
| Naphthalene Content | Up to 30,000 ppm | 0 ppm | −100% | Eliminates primary aerotoxic causal agent |
| Soot Mass (Idle / RTL) | Baseline (100%) | 20% of baseline | −80% | Eliminates deep-lung UFP inhalation risk for ground crews |
| Soot Particle Count (Idle) | Baseline (100%) | 45% of baseline | −55% | Directly reduces EU 2024/2493 Non-CO₂ impact metric |
| Total Hydrocarbons (UHC) | Baseline (100%) | 66.7% of baseline | −33.3% | Reduces fume event risk and VOC ground-level exposure |
| NOₓ Emissions (Idle) | Baseline (100%) | 80% of baseline | −20% | Airport air quality compliance benefit |
| CO Emissions (Idle) | Baseline (100%) | 91.7% of baseline | −8.3% | Crew cabin CO exposure reduction |
| Soot Particles (Full Load) | Baseline (100%) | 50–60% of baseline | −40 to −50% | Contrail nuclei reduction — key EU 2024/2493 metric |
| Seal Compatibility (NBR) | Naphthalene-dependent | Protected (cycloparaffins) | Maintained | Critical: legacy fleet drop-in compatibility assured |
| Fuel Density | 775–840 kg/m³ | 791.4 kg/m³ | Optimal | Ideal operational range — no range / performance adjustment required |
Section Four
Market Opportunity & Regulatory Context
4.1 The Aerotoxic Crisis — UK Ministry of Defence
Since 1999, UK military helicopter crews operating legacy rotorcraft have been subject to chronic exposure to the pyrolysis by-products of standard Jet A-1. The RAF Flight Sergeant Zach Stubbings case — settled by the MOD in January 2024 — established the precedent that is now driving 180+ claimants and 40–50 active collective legal challenges, prosecuted by Hugh James Law. The MOD's estimated aggregate liability exposure is GBP 360 million to GBP 900 million+ based on the Stubbings settlement quantum applied across the current claim pool.
The MOD is not, however, the only customer for tLCAF. It is the most urgent customer. Airlines, helicopter charter operators, search and rescue operations, air ambulance services and offshore energy aviation all face growing pressure from EU 2024/2493 and from their own occupational health obligations. The MOD engagement strategy is designed to create the commercial proof-of-concept that unlocks the much larger civil aviation market.
The MOD's continued use of standard Jet A-1 — after being formally presented with a validated, ASTM-certified, drop-in solution — will be characterised by claimants' counsel as ongoing, knowing breach of duty. Every day the MOD delays adoption after receiving DM-XTech's submission is a day that adds to the evidentiary record of deliberate inaction. This creates an accelerating incentive for MOD decision-makers to act.
4.2 EU Regulation 2024/2493 — Non-CO₂ Emissions
Regulation on Non-CO₂ Effects of Aviation on Climate Change
EU Regulation 2024/2493, which entered into force in 2024, establishes a mandatory framework for monitoring, reporting and ultimately reducing the non-CO₂ climate impacts of aviation — specifically contrails, soot particles, water vapour and NOₓ effects. The Regulation requires EU carriers to begin full non-CO₂ monitoring from 2025, with a regulatory review anticipated in 2027 that is widely expected to introduce mandatory reduction targets.
Contrails — formed when hot, soot-laden exhaust condenses around combustion particles — are estimated to cause approximately twice the warming effect of aviation CO₂ over a 20-year horizon. The nucleation mechanism depends directly on soot particle count in exhaust: fewer soot particles means fewer contrail nuclei. tLCAF's 40–50% reduction in full-load soot particle count is a direct contrail mitigation measure, positioning it as the only currently certified drop-in fuel that provides a measurable non-CO₂ reduction recognised under EU 2024/2493.
Airlines operating under EU Air Service Agreements — including all UK airlines operating to the EU under the UK-EU Trade and Cooperation Agreement — face this regulation. IAG (British Airways, Iberia, Aer Lingus, Vueling), Virgin Atlantic, EasyJet, Ryanair, Wizz Air and the full UK/EU carrier ecosystem are affected. First-adopter airlines that deploy tLCAF can demonstrate quantified non-CO₂ reduction in their EU 2024/2493 monitoring reports ahead of the 2027 review, establishing a compliance track record that will be valuable when mandatory targets are introduced.
4.3 Total Addressable Market
| Market Segment | Annual Volume (Est.) | Revenue Potential | Key Driver | Target Timing |
|---|---|---|---|---|
| UK MOD — Pilot Programme | 500–2,000 t | GBP 0.4–1.6M/yr | Aerotoxic litigation | 2026–2027 |
| UK MOD — Full Fleet | 15,000–25,000 t/yr | GBP 11–19M/yr | Duty of care / settlement avoidance | 2027–2028 |
| First-Adopter Airlines (UK/EU) | 50,000–200,000 t/yr | GBP 40–160M/yr | EU 2024/2493 Non-CO₂ compliance | 2027–2029 |
| NATO Allied Forces | 200,000+ t/yr | GBP 160M+/yr | Health & safety; NATO interoperability | 2028–2030 |
| UK/EU Civil Helicopter Ops | 50,000–100,000 t/yr | GBP 40–80M/yr | Occupational health regulation | 2027–2029 |
| Full EU Aviation Market | 18M+ t/yr | Multi-billion EUR/yr | EU 2024/2493 mandatory targets | 2030+ |
| Universal Marine Fuel (UK/EU) | 5M+ t/yr | GBP 2B+/yr | IMO 2020; EU ETS maritime | 2027+ |
| Euro7-Ready Diesel (UK/EU) | Large fleet ops | GBP 100M+/yr | EU7 legislation 2025–2028 | 2027+ |
Section Five
Validation Production Hub (VPH)
The Validation Production Hub (VPH) — sited within the University of Sheffield TERC compound — is the central capital deployment for this fundraising round and will be the world's first dedicated commercial production facility for naphthalene-free precision-aromatic aviation fuel. Designed with a nameplate capacity of 2,000 barrels per day (bpd), the VPH will operate as DM-XTech's primary revenue-generating asset for Phase 1 while simultaneously serving as the commercial validation platform required to anchor the Series B dedicated refinery financing.
5.1 Plant Specifications
| Parameter | Specification | Rationale |
|---|---|---|
| Location | TERC Compound, University of Sheffield | Academic oversight; analytical infrastructure; regulatory credibility |
| Design Capacity | 2,000 barrels per day (~100,000 tonnes/year at full utilisation) | Sized for MOD Pilot + airline CPOAs + zLCAF transition volumes |
| Initial Operating Capacity | 20,000–40,000 tonnes/year (20–40% utilisation) | Phased ramp-up as MOD and airline volumes confirmed |
| Process Technology | Catalytic hydrotreatment — licensed from DM-XTechnologies Inc. | Proven at APU validation scale; scaling to commercial volumes |
| Feedstock | Fossil crude oil (petroleum fractions) + aromatic blending components | Standard refinery-grade crude; available from UK/EU supply chain at GBP 400–550/tonne |
| Quality Assurance | In-line ASTM D1319 aromatic content monitoring; ASTM D4052 density; ICP-OES metals | Every production batch independently certified against ASTM D1655 and DEF STAN 91-091 |
| Academic Oversight | TERC independent QA review per batch | Investor-grade and MOD-grade quality assurance |
| Certifications | ASTM D1655; DEF STAN 91-091; EU aviation fuel quality regulations | Full commercial deployment readiness |
| Construction Timeline | 12–18 months from capital close | Equipment procurement 6 months; installation & commissioning 6–12 months |
| Estimated Capex | GBP 5.5–6.5M | Within Series A envelope; balance allocated to refinery FEED, 36-month operations and working capital |
5.2 VPH Design Capacity & Throughput by Fuel Type
| Fuel Type | Annual Throughput (tonnes) | % of Capacity | Notes |
|---|---|---|---|
| tLCAF (Transitional Low Carbon Aviation Fuel) | 70,000 | 70% | Primary product — MOD & airline supply; ASTM D1655 compliant |
| zLCAF (Zero-Aromatics Low Carbon Aviation Fuel) | 30,000 | 30% | Second-generation product — modern fleet aircraft; ASTM D7566 pathway |
| Total VPH Output | ~100,000 | 100% | Aviation fuels only at VPH; marine & diesel at commercial refinery |
Note: The VPH produces aviation fuels only (tLCAF and zLCAF). Universal Marine Fuel and Euro7-Ready Diesel are products of the dedicated commercial refinery (Series B), where the broader crude oil processing infrastructure supports multi-product output.
5.3 VPH Ramp-Up Schedule & Utilisation
| Year | Phase | Utilisation | tLCAF (tonnes) | zLCAF (tonnes) | Milestones |
|---|---|---|---|---|---|
| Year 1 (2026) | Construction | 0% | — | — | EPC procurement; installation; commissioning begins Q4 |
| Year 2 (2027) | Pilot Plant — Year 1 | 10–20% | 8,000–16,000 | 1,000–2,000 | First production; MOD Pilot supply; first airline CPOA deliveries |
| Year 3 (2028) | Pilot Plant — Year 2 | 30–50% | 21,000–35,000 | 9,000–15,000 | Full MOD ramp; airline CPOA expansion; Series B launch |
| Year 4 (2029) | Transition Year 1 | 60–80% | 42,000–56,000 | 18,000–24,000 | Dedicated refinery construction begins; VPH at near-max output |
| Year 5 (2030) | Transition Year 2 | 80–100% | 56,000–70,000 | 24,000–30,000 | VPH at full capacity; refinery Phase 1 nearing commissioning |
Transition Timeline: The VPH operates as a Pilot Plant for 2 years (2027–2028), establishing production economics, building the CPOA portfolio, and generating the commercial dataset for Series B. The transition to the dedicated commercial refinery spans 3 years (2029–2031), during which the VPH continues at full capacity while the refinery is constructed. Universal Marine Fuel and Euro7-Ready Diesel production begins only at the commercial refinery stage.
5.4 Pricing Assumptions
| Product | VPH / Pilot Stage Pricing | Commercial Refinery Pricing | Benchmark |
|---|---|---|---|
| tLCAF | 50% premium over Jet A-1 (~GBP 870/t) | Parity with Jet A-1 (~GBP 580/t) | Platts CIF NWE Jet; indexed quarterly |
| zLCAF | 100% premium over Jet A-1 (~GBP 1,160/t) | 25% premium over Jet A-1 (~GBP 725/t) | Platts CIF NWE Jet + premium schedule |
| Universal Marine Fuel | — (commercial refinery only) | Parity with VLSFO (~GBP 450–500/t) | Platts Singapore/Rotterdam VLSFO; indexed monthly |
| Euro7-Ready Diesel | — (commercial refinery only) | 5–10% premium over EN 590 diesel | ICE Gasoil; indexed monthly |
The pilot-stage premium for tLCAF (50% over Jet A-1) reflects scarcity value, first-mover regulatory compliance, and the cost profile of small-scale production. As scale increases at the commercial refinery, production economics improve to the point where tLCAF can be offered at parity with standard Jet A-1 — a critical price point for airline adoption at fleet scale. zLCAF retains a 25% premium at commercial stage, reflecting its superior environmental performance profile and the willingness of modern-fleet operators to pay for maximum contrail and emissions reduction under EU 2024/2493.
5.5 Feedstock & Unit Economics
| Parameter | Detail |
|---|---|
| Primary Feedstock | Fossil crude oil (petroleum distillate fractions) |
| Feedstock Source | UK/EU refinery supply chain; Brent-linked pricing |
| Cost Range | GBP 400–550 per tonne (crude-derived feedstock) |
| Blending Components | Aromatic fraction (cycloparaffins) — sourced separately |
| Supply Security | Multiple UK/EU refinery suppliers; no single-source dependency |
| Metric | VPH (Pilot) | Refinery (Scale) |
|---|---|---|
| Target Gross Margin | 10–15% | 25–35% |
| Operating Cost / tonne | GBP 688–712 | GBP 420–500 |
| Energy Consumption | Standard hydrotreatment | Optimised CHP integration |
| Refining Margin Basis | Conventional oil refinery crack spread economics | |
Unit economics at the VPH stage reflect pilot-scale production costs. At commercial refinery scale, DM-XTech targets conventional oil refinery operating economics — meaning production costs, energy consumption, maintenance schedules and staffing ratios are consistent with standard petroleum refinery operations, with the premium captured through the proprietary formulation and regulatory compliance value rather than production cost advantage.
5.6 Certification Pathway & Timeline
| Product | Primary Standard | Current Status | Target Completion | Additional Certifications |
|---|---|---|---|---|
| tLCAF | ASTM D1655 | COMPLIANT ✓ | Achieved | DEF STAN 91-091; EU aviation fuel quality; CORSIA-eligible pathway |
| zLCAF | ASTM D7566 | In TERC validation | 2027–2028 | CORSIA eligibility application; EU 2024/2493 compliance documentation |
| Universal Marine Fuel | ISO 8217 / IMO MARPOL Annex VI | Formulation stage | 2029 (with refinery) | IMO approval; EU ETS maritime compliance; SOLAS compatibility |
| Euro7-Ready Diesel | EN 590 / Euro 7 standards | Formulation stage | 2029 (with refinery) | EU7 type-approval testing; fleet operator validation programme |
5.7 Commercial Purpose of the VPH
MOD Operational Pilot Programme Supply
The Pilot Plant will fulfil the initial fuel supply requirement for the MOD Operational Pilot Programme at the target military airbase. Volume requirement estimated at 500–2,000 tonnes over the programme duration — well within plant capacity.
First-Adopter Airline Supply (CPOAs)
The Pilot Plant will supply initial tLCAF volumes under Contingent Product Offtake Agreements to first-adopter airlines seeking EU 2024/2493 compliance. Target airlines include IAG, Virgin Atlantic and EasyJet. Initial CPOA volumes are designed to be achievable within Pilot Plant capacity.
Commercial Validation Dataset
The Pilot Plant generates the commercial-scale production data — batch quality records, yield consistency, production economics, feedstock pricing — required to anchor the Series B dedicated refinery financing. Lab data alone is insufficient; refinery financiers and lenders require commercial-scale operating history.
zLCAF Transition Production
As TERC completes zLCAF validation, the Pilot Plant will be adapted to produce initial zLCAF batches for second-generation airline customers operating modern-fleet aircraft (A320neo, A350, B787) whose seal specifications accommodate zero-aromatic fuels.
Section Six
MOD Engagement Strategy
The MOD engagement strategy operates on four simultaneous vectors, each applying institutional pressure at a different level of the MOD decision architecture. The strategic objective is to reframe tLCAF adoption from a routine fuel procurement decision — which would take 2–4 years — to a legal risk management decision requiring urgent senior executive action.
Vector 1: Legal / Hugh James Route
Brief Hugh James Law's expert technical team with TERC validation data and ASTM/DEF STAN compliance documentation. Once tLCAF is formally on the legal record as an available, known remedy, continued MOD non-adoption becomes evidence of aggravated breach of duty. This is the most powerful accelerant to MOD action — it turns every week of inaction into additional litigation exposure.
Vector 2: DE&S Formal Submission
Simultaneous formal submission to the DE&S Commodity Fuels Team and the Health, Safety & Environmental Protection Directorate. Parallel submission to both procurement and safety directorates ensures the submission cannot be siloed within routine fuel procurement processes. Creates the official government record against which inaction becomes legally actionable.
Vector 3: Parliamentary Route
Briefing note to House of Commons Defence Select Committee MPs engaged with the aerotoxic issue. Parliamentary awareness that a validated solution exists and has been offered creates political accountability for MOD delay. The BBC's February 2025 reporting has already created public interest and media hooks that amplify parliamentary traction.
Vector 4: Surgeon General Route
Independent technical brief to the MOD Surgeon General's office activates the statutory health protection mandate through a channel separate from procurement. The Surgeon General's independent authority to issue Health Risk Assessments can effectively mandate procurement engagement, bypassing standard DE&S timelines.
6.1 The Pilot Programme Ask
DM-XTech's strategic ask to the MOD is not for full fleet adoption. It is for a funded, monitored Operational Pilot Programme at a single military airbase with high helicopter concentration — a 6-month programme framed not as a fuel R&D expense but as a legal insurance premium. The Pilot Programme cost represents less than 0.1% of the MOD's estimated aggregate aerotoxic liability exposure.
| Parameter | Specification |
|---|---|
| Target Airbase | UK Military Airbase — high helicopter concentration (RAF Benson, RAF Valley, RNAS Yeovilton or equivalent) |
| Duration | 6-month operational programme |
| Platform Target | Legacy rotorcraft: Chinook, Merlin, Puma, H135 Juno, H145 Jupiter |
| Fuel Volume | 500–2,000 metric tonnes over programme duration |
| Monitoring | Continuous particulate air quality monitoring; ground crew biomonitoring (naphthalene urinary metabolites); seal inspection at 500-hour intervals |
| Academic Oversight | TERC independent real-world data validation |
| MOD Legal Value | Active documented response to aerotoxic risk — immediate improvement to litigation defence position |
| MOD Health Value | Measurable, monitored reduction in crew exposure to naphthalene and UFPs from day one |
| DM-XTech Commercial Value | Real-world operational data confirming TERC APU results; MOD reference customer for airline CPOA negotiations |
Section Seven
Airline CPOA Strategy
Contingent Product Offtake Agreements (CPOAs) are commercial supply commitments from airlines — contingent on DM-XTech achieving commercial production capability — that represent binding forward purchase obligations for tLCAF volumes upon the triggering of defined production milestones. CPOAs serve three simultaneous functions in DM-XTech's commercial strategy: they demonstrate demand-side validation to Series B investors; they provide anchor revenue visibility for the dedicated refinery financing; and they give airlines a demonstrable EU 2024/2493 compliance pathway to present to regulators ahead of mandatory target implementation.
7.1 Target Airline Counterparties
| Airline / Group | Annual Fuel Consumption | CPOA Target Volume | Compliance Driver | Engagement Route |
|---|---|---|---|---|
| IAG (BA / Iberia / Aer Lingus / Vueling) | ~15–17M t/yr | 50,000–100,000 t/yr | EU 2024/2493 Non-CO₂; ESG commitments; Scope 3 reporting | Sustainability Director; Chief Operations Officer |
| Virgin Atlantic | ~2.5M t/yr | 10,000–25,000 t/yr | SAF commitment aligned; EU 2024/2493; first-mover positioning | Fuel & Sustainability Strategy team |
| EasyJet | ~3.5M t/yr | 15,000–30,000 t/yr | EU ETS costs; Non-CO₂ monitoring; cost-efficient drop-in | Fleet Operations Director; Procurement |
| Ryanair | ~7M t/yr | 20,000–50,000 t/yr | EU ETS exposure; EU 2024/2493; cost competitive drop-in | Chief Operating Officer; Fuel Management |
| Wizz Air | ~3M t/yr | 10,000–20,000 t/yr | EU 2024/2493; EU ETS; rapidly growing EU network | Technical Operations Director |
| Total CPOA Portfolio (Target) | — | 105,000–225,000 t/yr | Anchors Series B dedicated refinery financing | GBP 80–180M annual CPOA revenue at full deployment |
7.2 CPOA Structure
Each CPOA is structured as a 5-year forward supply commitment, with annual volume floors and ceilings, contingent on DM-XTech achieving defined production certification milestones. The CPOA price is indexed to Jet A-1 market rates plus a fixed premium of GBP 80–120 per tonne, reflecting the EU 2024/2493 compliance value delivered. Airlines pre-commit to the premium because it is categorically cheaper than any alternative Non-CO₂ abatement strategy, and the contract is structured to terminate without penalty if DM-XTech fails to achieve production milestones — removing downside risk for the airline counterparty.
CPOAs are not yet executed; they are the commercial development objective of the TERC Pilot Plant phase. The Pilot Plant's production capability and MOD reference contract are the two commercial credentials needed to execute CPOAs with the target airlines.
| Term | Detail |
|---|---|
| Duration | 5 years from first delivery |
| Volume Commitment | Annual floor / ceiling (TBD per airline) |
| Pricing | Jet A-1 index + GBP 80–120/t premium |
| Contingency | Conditional on DM-XTech production cert. milestones |
| Termination | No-penalty for airline if milestones not met |
| Extension | Automatic 2-year extension option for airline |
| Exclusivity | UK/EU distribution exclusivity via DM-XTech licence |
| Audit Rights | Airline right to TERC-overseen QA audit per batch |
Section Eight
Strategic Plan of Action
Immediate Actions
0 – 30 Days- Close Series A fundraising round (USD 50M / GBP 40M). Target: 6–10 institutional investors, family offices or strategic partners at GBP 3–8M each
- Submit formal tLCAF technical proposal to DE&S Commodity Fuels Team and HS&EP Directorate simultaneously
- Brief Hugh James Law expert technical team with TERC data and DEF STAN certification
- Issue Parliamentary briefing note to Defence Select Committee members
- Engage University of Sheffield on TERC Pilot Plant site agreement and planning permissions
- Instruct UK/EU patent counsel for tLCAF and hydrotreatment process patent filings
- Initiate preliminary engagement with IAG, Virgin Atlantic and EasyJet sustainability teams on EU 2024/2493 tLCAF solutions
Short-Term Actions
30 – 90 Days- Begin TERC Pilot Plant construction. Award EPC contract for hydrotreatment unit installation
- Commence dedicated refinery front-end engineering design (FEED). Engage EPC consultants for site identification and option agreements
- Commission Liability Quantification Report (independent legal counsel) for MOD aggregate exposure
- Follow up DE&S submission — request formal technical briefing meeting
- Escalate via Parliamentary and Surgeon General routes if no DE&S response within 30 days
- Execute Heads of Terms for first CPOA with one first-adopter airline
- Appoint UK/EU logistics partner (MOD-approved fuel supplier) for distribution framework
- Engage NATO Fuels Working Group (NFWG) for formal tLCAF introduction
Medium-Term Actions
90 – 180 Days- Complete Pilot Plant construction and commissioning. Achieve first commercial production batch certification
- Execute MOD Operational Pilot Programme agreement. Deliver first tLCAF supply
- Execute 2–3 CPOAs with first-adopter airlines. Minimum aggregate volume commitment: 50,000 t/yr
- Begin zLCAF scale-up validation programme at TERC alongside ongoing tLCAF production
- Commission Series B Investment Memorandum for dedicated refinery — anchored by CPOAs and MOD reference contract
- File UK and EU patent applications for tLCAF process and aromatic blend methodology
- Initiate engagement with US SPAC advisors (investment banks with deSPAC experience) for exit strategy planning
Long-Term Objectives
180 Days – 36 Months- Close Series B (GBP 80–120M) dedicated refinery financing. Begin refinery construction targeting 500,000+ t/yr capacity
- Achieve full UK MOD fleet adoption agreement — estimated 15,000–25,000 t/yr
- Scale CPOA portfolio to 200,000+ t/yr across 5+ airline counterparties
- Launch Universal Marine Fuel and Euro7 Diesel commercial programmes
- Complete zLCAF commercial validation and launch to modern-fleet airline customers
- Identify and advance discussions with target US NASDAQ SPAC for deSPAC merger (see Section 12)
- Achieve revenue run-rate of GBP 80–120M/yr to support deSPAC target valuation of USD 500M–2B
Section Nine
Financial Model & Projections
All financial projections are illustrative models based on TERC-validated production economics, prevailing jet fuel market prices (Q4 2025) and conservative volume assumptions. They are not profit forecasts. Actual results will depend on MOD procurement decisions, airline CPOA execution, regulatory developments, feedstock price movements and production scale-up execution. Investors should conduct independent financial due diligence.
9.1 Key Model Assumptions
| Item | Assumption |
|---|---|
| Jet A-1 Reference Price | GBP 580/tonne (Q4 2025 avg.) |
| Feedstock Hydrotreatment Cost | GBP 85–100/tonne incremental |
| Aromatic Blending Cost | GBP 15–20/tonne incremental |
| QA / Certification Cost | GBP 8–12/tonne |
| Total Production Cost (tLCAF) | GBP 688–712/tonne all-in |
| MOD Selling Price Target | GBP 780–820/tonne |
| Airline Selling Price Target | GBP 750–800/tonne |
| Gross Margin (Pilot Phase) | 10–15% (low scale) |
| Gross Margin (Scale Phase) | 20–30% (refinery economics) |
| Licence Royalty (to DM-XTech Inc.) | 3–5% of net revenue |
| Period | Volume | Basis |
|---|---|---|
| Year 1 (2026) | 0 tonnes | Plant construction; no revenue |
| Year 2 (2027) H1 | 2,000–5,000 t | Commissioning; MOD Pilot supply begins |
| Year 2 (2027) H2 | 5,000–10,000 t | First airline CPOA deliveries begin |
| Year 3 (2028) | 20,000–40,000 t | Full Pilot Plant + MOD + airline ramp |
| Year 4 (2029) | 80,000–150,000 t | Dedicated refinery Phase 1 + more CPOAs |
| Year 5 (2030) | 200,000–350,000 t | Full refinery; NATO expansion begins |
9.2 Five-Year Illustrative P&L
| Line Item | Year 1 (2026) | Year 2 (2027) | Year 3 (2028) | Year 4 (2029) | Year 5 (2030) |
|---|---|---|---|---|---|
| tLCAF Revenue — MOD | — | 1,560 | 7,800 | 19,500 | 19,500 |
| tLCAF Revenue — Airlines | — | 5,600 | 22,400 | 90,000 | 195,000 |
| zLCAF Revenue | — | — | 1,200 | 8,000 | 24,000 |
| Universal Marine Fuel Revenue | — | — | 600 | 6,000 | 18,000 |
| Euro7 Diesel Revenue | — | — | 400 | 4,000 | 12,000 |
| Total Revenue | — | 7,160 | 32,400 | 127,500 | 268,500 |
| Cost of Production (direct) | (800) | (6,050) | (24,300) | (89,250) | (175,725) |
| Gross Profit | (800) | 1,110 | 8,100 | 38,250 | 92,775 |
| Gross Margin | n/m | 15.5% | 25.0% | 30.0% | 34.6% |
| Licence Royalties (4% of revenue) | — | (286) | (1,296) | (5,100) | (10,740) |
| R&D, Regulatory & QA Costs | (800) | (700) | (900) | (1,500) | (2,500) |
| Sales, MOD & Airline Engagement | (1,000) | (800) | (1,000) | (1,800) | (3,200) |
| General & Administrative | (1,800) | (1,400) | (1,500) | (2,800) | (6,000) |
| EBITDA | (4,400) | (2,076) | 3,404 | 27,050 | 70,335 |
| EBITDA Margin | n/m | (29.0%) | 10.5% | 21.2% | 26.2% |
| TERC Plant Depreciation | — | (300) | (600) | (600) | (600) |
| Financing Costs (loan servicing) | — | (500) | (600) | (800) | (1,000) |
| Net Profit / (Loss) Before Tax | (4,400) | (2,876) | 2,204 | 25,650 | 68,735 |
9.3 Comparable Companies & Valuation Benchmarks
| Category | Company / Transaction | Market | Relevance to DM-XTech | Implied EV/Revenue |
|---|---|---|---|---|
| SAF Producers | Neste Oyj (NESTE.HE) | Helsinki | World's largest renewable aviation fuel producer; renewable diesel & SAF | 2.5–4.0x |
| World Energy (private) | US | First US refinery producing 100% SAF; acquired by Ariel Re | 3.0–5.0x | |
| SkyNRG (private) | NL | Leading SAF supply chain company; KLM / SHV partnership | n/a (pre-revenue) | |
| Renewable Diesel | Diamond Green Diesel (Valero JV) | US | 1.2B gal/yr renewable diesel; largest US producer | 4.0–6.0x |
| Renewable Energy Group (acquired by Chevron) | US | Acquired for USD 3.15B; 500M gal renewable diesel capacity | 3.5x (acq.) | |
| Gevo Inc. (GEVO) | NASDAQ | Alcohol-to-jet SAF; Net-Zero 1 project; deSPAC precedent | 8–15x (fwd) | |
| E-Fuels / Synthetic | HIF Global (Porsche-backed) | Chile / US | E-methanol to e-gasoline pathway; Haru Oni pilot plant | n/a (pre-revenue) |
| Infinium (private) | US | Electrofuel producer; Amazon / Infinium JV for e-SAF | n/a (pre-revenue) |
Valuation Context: Revenue-stage SAF and renewable diesel producers consistently trade at 3–6x EV/Revenue, reflecting the structural supply deficit in low-carbon fuels and the regulatory tailwind from CORSIA, EU ReFuelEU, and EU 2024/2493. Pre-revenue SAF companies (e.g. Gevo post-deSPAC) have achieved 8–15x forward revenue multiples, supported by committed offtake agreements. DM-XTech's CPOA-backed model with ASTM D1655-compliant product and MOD reference contract positions it at the premium end of the comparable range.
9.4 Sensitivity Analysis
| Scenario | MOD Volume | Airline Volume | Avg. Selling Price | Year 3 Revenue | Year 3 EBITDA |
|---|---|---|---|---|---|
| Base Case | 10,000 t | 30,000 t | GBP 800/t | GBP 32.0M | GBP 3.8M |
| Conservative Case | 2,000 t | 10,000 t | GBP 760/t | GBP 9.1M | (GBP 1.2M) |
| Optimistic Case | 25,000 t | 60,000 t | GBP 820/t | GBP 69.7M | GBP 16.4M |
| MOD Only (No Airlines) | 25,000 t | 0 | GBP 800/t | GBP 20.0M | GBP 1.2M |
| Airlines Only (MOD Delays) | 0 | 40,000 t | GBP 780/t | GBP 31.2M | GBP 3.4M |
9.5 Cash Flow & Funding Bridge
| Line Item | Year 1 (2026) | Year 2 (2027) | Year 3 (2028) | Year 4 (2029) | Year 5 (2030) |
|---|---|---|---|---|---|
| EBITDA | (4,400) | (2,076) | 3,404 | 27,050 | 70,335 |
| Working Capital Movement | (500) | (1,500) | (2,500) | (5,000) | (8,000) |
| Capex — VPH (TERC) | (5,800) | (700) | — | — | — |
| Capex — Refinery FEED & Site | (2,000) | (3,500) | (Series B) | (Series B) | — |
| Interest & Financing Paid | — | (500) | (600) | (800) | (1,000) |
| Tax Paid | — | — | — | (2,565) | (13,747) |
| Net Operating Cash Flow | (12,700) | (8,276) | 304 | 18,685 | 47,588 |
| Series A Proceeds (USD 50M / GBP 40M) | 40,000 | — | — | — | — |
| Series B Proceeds (GBP 80–120M) | — | — | 100,000 | — | — |
| Opening Cash Balance | — | 27,300 | 19,024 | 119,328 | 138,013 |
| Closing Cash Balance | 27,300 | 19,024 | 119,328 | 138,013 | 185,601 |
Note on Series A Runway: The Series A (USD 50M / GBP 40M) provides an uninterrupted 36+ month operating runway through to Q1 2029 without requiring bridge financing. The closing cash balance remains comfortably positive throughout Years 1 and 2, enabling the Company to invest aggressively in refinery front-end engineering (GBP 6M allocated to FEED and site acquisition), accelerated R&D for zLCAF, Marine Fuel and Euro7 Diesel, and a full C-suite management team from day one. The Series B (GBP 80–120M for dedicated refinery construction) is targeted for Year 3 (2028), anchored by the executed CPOAs, MOD Pilot Programme reference contract and TERC Pilot Plant operating data. The Series B financing is expected to be the pivotal value inflection event for Series A investors, either as a conversion / dilution event or as a secondary liquidity opportunity.
Section Ten
Use of Proceeds — Series A (USD 50M / GBP 40M)
| Category | Item | Amount (GBP) | % of Total | Rationale |
|---|---|---|---|---|
| TERC Pilot Plant Capex | Hydrotreatment unit procurement & installation | 3,200,000 | 8.0% | Core production asset — catalytic reactor, heat exchangers, pumps, compressors |
| Aromatic blending and QA instrumentation | 1,200,000 | 3.0% | ASTM D1319 in-line monitoring; ASTM D4052 density; ICP-OES metals; GC-MS | |
| Storage tankage & materials handling | 800,000 | 2.0% | Feedstock receiving, intermediate and product storage at TERC | |
| Site preparation, utilities & infrastructure | 1,000,000 | 2.5% | TERC compound integration; HSE compliance; utility connections; security | |
| Refinery Front-End Engineering | Front-end engineering design (FEED) for dedicated refinery | 3,600,000 | 9.0% | EPC contractor engagement; process design; permitting; environmental impact assessment |
| Site identification, option agreements & deposits | 2,400,000 | 6.0% | UK/EU sites with port access and petrochemical feedstock proximity | |
| Production Operations (36 Months) | Feedstock procurement (36-month supply) | 4,000,000 | 10.0% | MOD Pilot Programme supply; airline CPOA first deliveries; strategic inventory |
| Production staffing (36 months) | 2,400,000 | 6.0% | Plant operators, QA chemists, TERC liaison staff, shift supervisors | |
| Commercial & Legal | MOD engagement, legal counsel, Parliamentary & Surgeon General strategy | 1,600,000 | 4.0% | DE&S submissions, Parliamentary briefings, Liability Quantification Report, legal team |
| Airline CPOA negotiation, execution & commercial team | 1,200,000 | 3.0% | Commercial team, legal, travel for IAG / Virgin / EasyJet / Ryanair negotiations | |
| NATO & international military engagement | 400,000 | 1.0% | NFWG engagement; allied force briefings; international regulatory submissions | |
| IP & Regulatory | UK & EU patent filings & prosecution | 600,000 | 1.5% | tLCAF formulation, hydrotreatment process, aromatic blend method, QA protocols |
| TERC QA programme & batch certification (36 months) | 800,000 | 2.0% | Independent TERC certification for each commercial production batch | |
| R&D | zLCAF accelerated validation programme | 2,000,000 | 5.0% | TERC validation, ASTM D7566 certification pathway, modern-fleet seal testing |
| Universal Marine Fuel & Euro7 Diesel development | 1,000,000 | 2.5% | Commercial-scale validation; IMO compliance testing; EU7 certification | |
| Management & G&A | C-suite management team (CEO, CTO, CFO, Head of Commercial — 36 months) | 4,000,000 | 10.0% | Full executive team from day one; competitive compensation for specialist recruitment |
| General & administrative, office, insurance, compliance | 2,800,000 | 7.0% | Office, professional services, D&O insurance, audit, reporting, travel | |
| Working Capital & Contingency | Operational contingency, feedstock price variance, construction buffer | 4,000,000 | 10.0% | Construction overrun reserve; feedstock price hedge; operational contingency |
| Series B & deSPAC Preparation | Investment bank retainers, SPAC advisory, Series B IM, investor roadshow | 3,000,000 | 7.5% | deSPAC advisor retainer; Series B IM preparation; US investor roadshow; SEC counsel |
| TOTAL | 40,000,000 | 100.0% | USD 50M / GBP 40M Series A Target | |
10.1 Investment Terms — Series A
| Term | Specification | Notes |
|---|---|---|
| Instrument | Convertible Loan Note (CLN) or Equity Subscription | Investor preference; CLN structure preferred by Company for flexibility |
| Total Round Size | USD 50,000,000 (GBP 40,000,000 equivalent) | Target: 6–10 investors at GBP 3–8M each |
| Minimum Subscription | GBP 2,000,000 per investor | Qualified investors only (FCA Article 48 / Article 50) |
| Pre-Money Valuation | GBP 80–120M (to be confirmed) | Based on IP licence value, TERC validation, TAM, regulatory moat, market position |
| CLN Interest Rate | 8% per annum, accruing simple | Payable at maturity or conversion |
| CLN Maturity | 36 months from issue | Extension option of 12 months at Company's election |
| Conversion Trigger | Series B funding round at GBP 50M+ or deSPAC announcement | Automatic conversion at 20% discount to trigger event valuation |
| Equity Conversion Discount | 20% to Series B / deSPAC valuation | Reward for early-stage risk |
| Investor Governance Rights | Board observer seat (GBP 2M+ investors); monthly management accounts; quarterly board updates | Investor protection rights standard for Series A |
| Anti-Dilution Protection | Weighted average anti-dilution on any down round | Standard investor protection |
| Pro-Rata Rights | Pro-rata participation rights in Series B | Enables investors to maintain ownership on Series B close |
| Security (CLN) | IP charge (tLCAF licence rights); TERC Plant assets; floating charge on Company assets | First-ranking security in event of insolvency |
| MFN Clause | Most Favoured Nation — any subsequent Series A investor on same or better terms | First-close investor protection |
| Exit / Liquidity | Target 36–48 months — deSPAC / NASDAQ, strategic acquisition, or secondary sale | See Section 12 for exit detail |
Section Eleven
Dedicated Refinery & Series B Scale-Up
The TERC Pilot Plant is a proof-of-concept and initial revenue generator. The step-change in DM-XTech's financial trajectory — and the value creation event for Series A investors — is the construction of a dedicated commercial refinery with the capacity to supply the CPOA volumes committed by airlines and the full UK MOD fleet. The dedicated refinery is the asset that transforms DM-XTech from a pilot-scale technology company into a large-scale energy producer.
11.1 The CPOA-Backed Financing Model
The strategic genius of the CPOA structure is that it converts future airline revenue commitments into debt or equity financing collateral. By the time the Series B is launched (targeted 2028), DM-XTech will hold a portfolio of executed CPOAs representing 100,000+ tonnes/year of contracted tLCAF offtake from investment-grade airline counterparties. These CPOAs are the cornerstone of the refinery financing — they allow lenders and investors to underwrite project finance against contracted cash flows rather than speculative demand.
| Parameter | Specification |
|---|---|
| Target Location | UK or EU with port access; proximity to petrochemical feedstock supply chain and aviation fuel distribution hubs |
| Phase 1 Capacity | 500,000 tonnes/year (tLCAF + zLCAF combined) |
| Phase 2 Capacity (expansion) | 1,000,000+ tonnes/year including Universal Marine Fuel and Euro7 Diesel |
| Estimated Phase 1 Capex | GBP 80–100M (inclusive of land, equipment, installation and commissioning) |
| Financing Structure | 30% equity / 70% project finance debt (CPOA-collateralised); no government subsidies or incentive programmes assumed |
| Debt Collateral | Executed CPOAs with investment-grade airline counterparties; DM-XTech IP charge; Refinery asset mortgage |
| Series B Equity Target | GBP 80–120M |
| Construction Timeline | 24–30 months from Series B close |
| First Production (Refinery) | 2029 (Base Case) |
| Break-Even Volume | ~100,000 tonnes/year (well within CPOA committed volumes) |
| Target EBITDA at Full Utilisation | GBP 100–150M/year (Phase 1 capacity) |
Section Twelve
Exit Strategy — deSPAC & NASDAQ Listing
DM-XTech's primary exit strategy for investors is a deSPAC transaction within 2 years of Series A close (target: H1 2028) — a merger with a US-based, large-capitalisation Special Purpose Acquisition Company (SPAC) listed on the NASDAQ exchange. The accelerated 2-year timeline is achievable because the Company will have TERC-validated production data, executed MOD and airline contracts, and a growing revenue base within 18 months of close. This exit mechanism is strategically superior to a conventional IPO or trade sale: it provides access to the deep US capital markets required to fund multi-refinery international expansion; it accelerates the listing timeline relative to a traditional IPO roadshow; it enables the merged entity to raise substantial additional capital at or after the SPAC transaction; and it positions the Company within the US energy and clean technology investment universe.
12.1 The deSPAC Process — How It Works
12.2 Target SPAC Profile & Valuation Framework
| Attribute | Target |
|---|---|
| Market | NASDAQ (preferred) or NYSE |
| Trust Size | USD 200–500M |
| SPAC Focus | Energy transition, clean tech, decarbonisation |
| Sponsor Profile | Energy-sector PE / institutional sponsor |
| SPAC Status | Within extension period (motivated to close) |
| Geographic Focus | Global / UK-EU expansion capability |
| Scenario | Implied Enterprise Value |
|---|---|
| Conservative (5x Year 5 EBITDA) | USD 350M (GBP 280M) |
| Base Case (8x Year 5 EBITDA) | USD 560M (GBP 448M) |
| Optimistic (12x Year 5 EBITDA) | USD 840M (GBP 672M) |
| Strategic Premium (SAF scarcity) | USD 1.5–2B (GBP 1.2–1.6B) |
| Target deSPAC Valuation | USD 500M – 2B |
12.3 Series A Investor Return Analysis
| Exit Scenario | DeSPAC Valuation | Series A Conversion (20% disc) | Return on GBP 1M (illustrative) | Multiple (Gross) |
|---|---|---|---|---|
| Conservative | GBP 280M | Series B @20% disc. | GBP 2.5M | 2.5x |
| Base Case | GBP 448M | Series B @20% disc. | GBP 4.0M | 4x |
| Optimistic | GBP 672M | Series B @20% disc. | GBP 6.0M | 6x |
| Strategic Premium | GBP 1.2–1.6B | Series B @20% disc. | GBP 11–14M | 11–14x |
The deSPAC exit is not solely a liquidity event — it is an accelerant to DM-XTech's commercial mission. By accessing USD capital markets, the merged entity gains the balance sheet capacity to construct multiple refineries simultaneously, accelerate NATO expansion, and commercialise the Universal Marine Fuel and Euro7 Diesel lines in parallel. A USD 200–500M SPAC trust plus PIPE proceeds transforms DM-XTech's addressable market from UK/EU aviation into a global multi-sector low-carbon fuels business.
Section Thirteen
Risk Factors
Investment in DM-XTech UK Ltd involves material risks. The following is not an exhaustive list. Prospective investors should obtain independent legal and financial advice before proceeding.
13.1 Regulatory & Procurement Risks
| Risk | Probability | Impact | Mitigation |
|---|---|---|---|
| MOD delays or declines Pilot Programme | MEDIUM | Loss of MOD as anchor customer; commercial credibility reduced | Four-vector strategy; airline CPOAs provide independent revenue path; Parliamentary pressure |
| EU 2024/2493 mandatory targets delayed | LOW | Airlines reduce urgency of CPOA execution | Monitoring phase still active from 2025; airlines have own ESG commitments; voluntary adoption continues |
| ASTM D7566 approval for zLCAF delayed | MEDIUM | zLCAF commercial launch delayed; tLCAF revenue extended | tLCAF is primary revenue product; zLCAF is additive; TERC validation data accelerates ASTM engagement |
| UK/EU regulatory change to fuel standards | LOW | Potential recertification costs | ASTM D1655 is a global standard; DEF STAN 91-091 is UK MOD-controlled; both are stable long-term frameworks |
13.2 Operational & Production Risks
| Risk | Probability | Impact | Mitigation |
|---|---|---|---|
| VPH construction overruns (cost / time) | MEDIUM | Cash flow pressure; delayed first production; potential need for bridge financing | GBP 4M contingency reserve in use of proceeds; fixed-price EPC contract structure; TERC institutional oversight |
| Production quality inconsistency (batch variance) | LOW | ASTM D1655 / DEF STAN 91-091 non-compliance risks shipment rejection | TERC independent QA per batch; in-line ASTM D1319 aromatic monitoring; ICP-OES metals analysis |
| Feedstock supply / price disruption | MEDIUM | Production cost overruns; margin compression | Multiple feedstock suppliers; Jet A-1 price pass-through in CPOA pricing formula; feedstock hedging considered |
| Key person dependency (technical team) | MEDIUM | Production capability impaired if key technical staff leave | TERC institutional knowledge sharing; IP licensor (DM-XTech Inc.) technical support obligations |
13.3 Commercial & Financial Risks
| Risk | Probability | Impact | Mitigation |
|---|---|---|---|
| Airlines delay CPOA execution pending MOD proof-of-concept | MEDIUM | Series B timeline extended; cash flow pressure | MOD Pilot Programme is primary CPOA accelerant; airline EU 2024/2493 pressure independent of MOD |
| Competitor develops alternative naphthalene-free fuel | LOW | Price pressure; reduced competitive moat | IP licensing protection; first-mover MOD relationship; TERC validation data moat; patent filings |
| Jet A-1 price decline (reduces tLCAF premium attractiveness) | LOW | Airlines renegotiate CPOA pricing | CPOAs priced on premium over Jet A-1 index (not absolute price); health/compliance value persists regardless of commodity price |
| Series B fails to close or closes on unfavourable terms | LOW | Refinery construction delayed; growth constrained to Pilot Plant capacity | CPOA portfolio makes Series B highly bankable; VPH generates positive EBITDA from Year 3 as standalone business |
| deSPAC market conditions deteriorate (SPAC market cycle) | MEDIUM | Exit timeline extended; investors may require alternative liquidity mechanisms | Strategic trade sale alternative; secondary PE market for CLN / equity; standalone profitable business as fallback |
13.4 Licence & IP Risks
| Risk | Probability | Impact | Mitigation |
|---|---|---|---|
| DM-XTechnologies Inc. licence dispute or default | LOW | Production rights in UK/EU potentially challenged | Robust licence agreement with step-in rights; DM-XTech's own UK/EU patent filings provide independent IP position |
| Third-party IP challenge to tLCAF process | LOW | Production disruption; legal costs | Prior art analysis conducted; TERC developed process independently; DM-XTech own patent filings provide prior art |
Section Fourteen
Appendices & Technical Reference
Appendix A: Full TERC Validation Dataset
| Measurement | Method | Jet A-1 Value | tLCAF Value | Change |
|---|---|---|---|---|
| Naphthalene content | ASTM D1319 / GC-MS | Up to 30,000 ppm | 0 ppm | −100% |
| Total aromatic content | ASTM D1319 | ~18–22% vol | 8.5% vol | −58% |
| Soot mass concentration (idle) | DMS500 spectrometer | Baseline | 20% of baseline | −80% |
| Particle number (idle, 23nm cutoff) | DMS500 spectrometer | Baseline | 45% of baseline | −55% |
| Total unburned hydrocarbons (idle) | FTIR gas analyser | Baseline | 66.7% of baseline | −33.3% |
| NOₓ (NO + NO₂) — idle | Chemiluminescence | Baseline | 80% of baseline | −20% |
| CO — idle | NDIR analyser | Baseline | 91.7% of baseline | −8.3% |
| Particle number (full power) | DMS500 spectrometer | Baseline | 50–60% of baseline | −40 to −50% |
| Density at 15°C | ASTM D4052 | 775–840 kg/m³ | 791.4 kg/m³ | Ideal mid-range |
| Calcium content | ICP-OES | <0.5 mg/kg | <0.037 mg/kg | Ultra-low |
| Lead content | ICP-OES | <0.01–0.1 mg/kg | <0.011 mg/kg | Ultra-low |
| ASTM D1655 compliance | Full specification | Pass | Pass | Certified |
| DEF STAN 91-091 compliance | Full specification | Pass | Pass | Certified |
Appendix B: Key Regulatory Framework Summary
| Regulation / Standard | Jurisdiction | Relevance to DM-XTech | Status |
|---|---|---|---|
| EU Regulation 2024/2493 | European Union | Non-CO₂ aviation emissions — primary driver of airline CPOA demand for tLCAF | In force. Monitoring 2025; mandatory targets review 2027 |
| UK-EU Trade & Cooperation Agreement | UK / EU | Governs UK airline operating rights into EU airspace — UK airlines subject to EU environmental standards | In force |
| EU Emissions Trading Scheme (EU ETS) | European Union | Aviation carbon cost — tLCAF soot/contrail reduction reduces overall climate impact metric; SAF credit pathways | Extended. Aviation included in revised EU ETS from 2024 |
| RefuelEU Aviation (EU 2023/2405) | European Union | Mandates SAF blending at EU airports. tLCAF pathway for SAF credit under review | In force from 2025 (2% SAF minimum) |
| IMO 2020 Sulphur Cap | Global Maritime | Universal Marine Fuel is IMO 2020 compliant — key commercial driver | In force |
| EU ETS Maritime Extension | European Union | Shipping included in EU ETS from 2024 — creates demand for cleaner marine fuels | In force 2024 |
| EU7 Vehicle Emission Standards | European Union | Euro7-Ready Diesel — pre-compliant with forthcoming light-duty (2025) and heavy-duty (2028) standards | Adopted. LD implementation 2025; HD implementation 2028 |
| ASTM D1655 | Global (Civil Aviation) | Primary civil jet fuel specification — tLCAF fully certified | Certified |
| DEF STAN 91-091 | UK (Military) | UK MOD aviation fuel specification — tLCAF fully certified | Certified |
| ASTM D7566 | Global (SAF) | SAF specification — zLCAF pursuing ASTM D7566 Annex certification pathway | In progress |
| NATO STANAG 3747 | NATO | Military aviation fuel standardisation — pathway for NATO-wide tLCAF adoption via NFWG | DM-XTech NFWG engagement planned |
Appendix C: Glossary
| Term | Definition |
|---|---|
| tLCAF | Transitional Low Carbon Aviation Fuel — DM-XTech's precision-engineered, naphthalene-free hydrotreated jet fuel with 8.5% cycloparaffin aromatic content for legacy seal compatibility |
| zLCAF | Zero-Aromatics Low Carbon Aviation Fuel — DM-XTech's next-generation fully zero-aromatic fuel for modern aircraft with PTFE/FFKM seals |
| CPOA | Contingent Product Offtake Agreement — binding future supply commitment from an airline, contingent on DM-XTech achieving production milestones |
| TERC | Translational Energy Research Centre, University of Sheffield — DM-XTech's validation and production partner |
| deSPAC | De-SPAC transaction — merger of a private company with a publicly listed SPAC, resulting in the private company becoming publicly listed |
| SPAC | Special Purpose Acquisition Company — a shell company listed on a stock exchange for the purpose of acquiring a private company |
| PIPE | Private Investment in Public Equity — concurrent private placement alongside a deSPAC transaction to raise additional capital |
| Naphthalene | C₁₀H₈ — bicyclic aromatic hydrocarbon in standard Jet A-1 (up to 30,000 ppm) identified as primary causal agent in aerotoxic syndrome |
| PAH | Polycyclic Aromatic Hydrocarbon — highly toxic combustion by-product of naphthalene pyrolysis; associated with multiple myeloma, hemolytic anemia and neurotoxicity |
| NBR Seal | Nitrile Butadiene Rubber seal — legacy aircraft fuel system component requiring minimum aromatic solvency for integrity |
| DE&S | Defence Equipment and Support — MOD's procurement and logistics agency, responsible for fuel procurement |
| HS&EP | Health, Safety and Environmental Protection Directorate — MOD statutory safety oversight body |
| NFWG | NATO Fuels Working Group — the NATO standardisation body for military aviation fuel specifications |
| UFP | Ultrafine Particles — combustion particulates ≤100nm; penetrate deep lung tissue and the blood-brain barrier |
| EPC | Engineering, Procurement and Construction — the standard contract structure for industrial plant construction |
| CLN | Convertible Loan Note — a debt instrument that converts to equity at a defined trigger event |
Appendix D: Key Contacts & Next Steps
Investor Enquiries & Due Diligence
Qualified investors wishing to proceed to due diligence should contact DM-XTech UK Ltd directly. A full due diligence data room will be made available following execution of a Non-Disclosure Agreement. The data room contains: full TERC validation reports; ASTM D1655 and DEF STAN 91-091 certification documents; draft CPOA term sheet; draft MOD submission package; DM-XTechnologies Inc. licence agreement summary; IP status report; audited / management accounts; and the full Series A term sheet.
Website: www.dmxtech.co.uk | Classification: Strictly Confidential — Qualified Investors Only
Validation Partner: Translational Energy Research Centre (TERC), The University of Sheffield, UK | IP Licensor: DM-XTechnologies Inc.